| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6246885 | Transplantation Proceedings | 2016 | 5 Pages |
Abstract
In SPKT, CFR ⤠2 may be a reliable marker for MACE, independent of coronary artery disease diagnosis. However, this role seems to be reduced over time. This finding suggests a gradual reduction of cardiovascular risk in SPKT patients.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
F. Tona, C. Silvestre, M. Rigato, G. Famoso, F. Marchini, L. Bonfante, F. Neri, L. Furian, C. Crepaldi, S. Iliceto, P. Rigotti,